| Breakdown | TTM | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 39.31B | 37.34B | 35.92B | 33.03B | 30.88B | 28.32B |
| Gross Profit | 16.37B | 15.57B | 14.33B | 13.38B | 12.58B | 11.15B |
| EBITDA | 1.20B | 3.01B | 1.38B | 1.88B | 2.23B | 996.80M |
| Net Income | 298.00M | 888.00M | -106.00M | 385.00M | 773.00M | -220.64M |
Balance Sheet | ||||||
| Total Assets | 32.58B | 29.16B | 25.83B | 23.13B | 20.51B | 20.43B |
| Cash, Cash Equivalents and Short-Term Investments | 2.26B | 2.32B | 2.62B | 1.56B | 1.62B | 1.39B |
| Total Debt | 8.82B | 7.50B | 6.19B | 5.97B | 3.67B | 3.91B |
| Total Liabilities | 21.18B | 18.21B | 15.66B | 14.99B | 12.71B | 13.30B |
| Stockholders Equity | 11.11B | 10.94B | 10.14B | 8.11B | 7.80B | 7.11B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -591.00M | -1.29B | -2.38B | 611.00M | -943.39M |
| Operating Cash Flow | 0.00 | 3.76B | 2.08B | 1.27B | 2.51B | 655.42M |
| Investing Cash Flow | 0.00 | -5.18B | -3.41B | -3.63B | -1.92B | -17.39M |
| Financing Cash Flow | 0.00 | 1.11B | 2.39B | 2.27B | -396.00M | -191.03M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥21.80B | 20.09 | ― | ― | ― | ― | |
63 Neutral | ¥23.19B | 146.77 | ― | 1.20% | 3.89% | -12.08% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | ¥22.97B | 35.55 | ― | 0.78% | 8.86% | -17.71% | |
60 Neutral | ¥22.03B | -115.94 | ― | 0.77% | ― | ― | |
60 Neutral | ¥21.32B | 25.72 | ― | 0.75% | 25.41% | 77.18% | |
54 Neutral | ¥18.99B | 14.00 | ― | 0.54% | 1.09% | -128.63% |